Today, Insilico Medicine, a biotech company developing the end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, announces its partnership with Arctoris, the world's first fully automated cancer research laboratory providing robotic experimentation in the cloud, Science Entrepreneur Club, a life sciences network and Clustermarket, a leading online equipment sharing and booking platform enabling and accelerating science.
The goal of this collaboration is to conduct BioTarget, which is dedicated to finding new molecules for cancer treatments from collaborating partners worldwide, and to raising awareness for entrepreneurship and innovation amongst scientists. We also aspire to unite the life science ecosystem by educating, inspiring biotech companies to form powerful connections and receive grants for experiments. The initiative is supported by Cancer Research UK, the world's largest independent cancer research charity organisation.
Read full article here.